Skip to content

Comparison of "Tramadol" versus "Ondansetron" in prevention of post spinal shivering

Comparison of Tramadol versus Ondansetron in prevention of post anesthetic shivering under subarachnoid block for lower limb and lower abdominal surgeries-a prospective, randomized, double blind trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035950
Enrollment
80
Registered
2021-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intravenous Tramadol: Group T will be receiving Inj.Teamadol 0.5 mg/kg intravenously immediately after spinal anesthesia Control Intervention1: Comparison of Tramadol versus Ondansetron

Sponsors

Dr Renita Dcosta
Lead Sponsor
Dr Ashwini H R
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: American society of anesthesiologist physical status grade I and II Patients posted for elective and emergency lower abdominal and lower limb surgeries Patients with valid informed consent

Exclusion criteria

Exclusion criteria: Patients with contraindication to regional anesthesia Patients with deformities of spine Patients with thyroid disease,history of convulsions,multiple allergies,pregnancy, uncooperative patients and patients requiring blood transfusion

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Ondansetron versus Tramadol in prevention of post spinal shivering in lower abdominal and lower limb surgeriesTimepoint: Nibp,heart rate,spo2,body temperature and grade of shivering monitored for every 5 mins in the initial 30mins, every 10 mins till 60 mins and every 15 minutes in next houurs

Secondary

MeasureTime frame
To compare the hemodynamic parameters such as heart rate, blood pressure and spo2Timepoint: Heart rate, blood pressure and spo2 checked for every 5 mins in the initial 30 mins ,every 10bmins untill 60 mins and every 15 mins in next hours

Countries

India

Contacts

Public ContactDr Ashwini H R

Karnataka Institute of Medical Sciences HUbballi

ashvenki.hubli@gmail.com9480523670

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026